Human Integrin beta 2/CD18 Antibody, R&D Systems™

Integrin beta 2/CD18

Monoclonal

LYOPH

Western Blot 1 ug/mL, Flow Cytometry 2.5 ug/10^6 cells, Immunocytochemistry 8-25 ug/mL, CyTOF-ready

AAA59490

ITGB2

Mouse myeloma cell line NS0-derived recombinant human Integrin beta 2/CD18 Gln23-Asn700 Accession # AAA59490

500 μg

Primary

Detects human Integrin beta 2/CD18 in direct ELISAs and Western blots. In direct ELISAs, no cross-reactivity with recombinant human Integrin beta 1 or recombinant mouse Integrin alpha 5 is observed.

Human

Purified

Western Blot, Flow Cytometry, Immunocytochemistry, CyTOF

212701

Unconjugated

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

959 beta subunit precursor)10, CD18, CD18 antigen, CD18beta 2, cell surface adhesion glycoprotein (LFA-1, CR3, integrin beta-2, integrin, beta 2 (antigen CD18 (p95), lymphocyte function-associated antigen 1;macrophage antigen 1 (mac-1) beta subunit), integrin, beta 2 (complement component 3 receptor 3 and 4 subunit), ITGB2, LAD, LCAMB, leukocyte cell adhesion molecule CD18, leukocyte-associated antigens CD18/11A, CD18/11B, CD18/11C, LFA-1, LFA-1 beta, MAC-1 beta, MF17, MFI7, P150, p150,95 beta

Mouse

Protein A or G purified from hybridoma culture supernatant

RUO

3689

Reconstitute at 0.5 mg/mL in sterile PBS.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

IgG1